| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers B > Headlines for Boston Scientific Corp. > News item |
Fitch gives Boston Scientific notes BBB
Fitch Ratings said it assigned a BBB rating to Boston Scientific Corp.'s (BSX) senior unsecured notes offering.
The company intends to use the net proceeds to redeem outstanding debt.
The outlook is stable. The ratings apply to about $5.62 billion of debt outstanding as of Dec. 31, 2017.
“Boston Scientific has done a good job returning its business to consistent profitable growth. The company has stabilized its Cardiac Rhythm Management (CRM) and drug-eluting stent (DES) segments, with the prospects of generating mid-single-digit growth during the long-term,” Fitch said in a news release.
“BSX has and will continue to introduce internally- or externally-developed new products into these two markets, offering the company a number of opportunities to increase share and revenue.
“Longer-term, BSX's investments in emerging markets will likely support moderate but steady revenue growth.”
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.